High materiality9/10
Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James
Why it may matterVerify against the original reporting
Very bullish due to substantial upside vs current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Raymond James initiated TNXP with a Strong Buy; target $26 vs current price $12.10.
- RJ target $26; current $12.10.
Key facts
- 01
Target: $26
- 02
Posted price: $12.1
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.